Examining the Utility of In Vitro Bioactivity as a Conservative Point of Departure: A Case Study

2018-10-23T21:11:07Z (GMT) by Katie Paul-Friedman
Presentation to the Advancing the Pace of Chemical Risk Assessment (APCRA) team meeting Oct 2018